Effects of aprotinin on anticoagulant monitoring: implications in cardiovascular surgery.

[1]  R. Mohr,et al.  Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. , 1993, The Annals of thoracic surgery.

[2]  F. Loop,et al.  Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.

[3]  R. Mohr,et al.  Original articlePlatelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic study , 1992 .

[4]  J. E. Doran,et al.  Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. , 1991, The Journal of thoracic and cardiovascular surgery.

[5]  H. Teufelsbauer,et al.  Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation. , 1991, The Journal of thoracic and cardiovascular surgery.

[6]  W. van Oeveren,et al.  Increased anticoagulation during cardiopulmonary bypass by aprotinin. , 1990, The Journal of thoracic and cardiovascular surgery.

[7]  R. Hart,et al.  Hematologic disorders and ischemic stroke. A selective review. , 1990, Stroke.

[8]  W. van Oeveren,et al.  Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[9]  J. Griffin,et al.  Aprotinin (trasylol) is a competitive inhibitor of activated protein C. , 1989, Thrombosis research.

[10]  V. Boddi,et al.  High-dose aprotinin: hemostatic effects in open heart operations. , 1989, The Annals of thoracic surgery.

[11]  G. Fraedrich,et al.  Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results , 1989, The Thoracic and cardiovascular surgeon.

[12]  F. Sebening,et al.  Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical Patients , 1989, The Thoracic and cardiovascular surgeon.

[13]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[14]  T. Nilsson,et al.  The extrinsic fibrinolytic system in survivors of myocardial infarction. , 1987, Thrombosis research.

[15]  A. Montoya,et al.  Management of postoperative heparin rebound following cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.